New eye drop formula enters testing to fight Vision-Threatening pressure
NCT ID NCT07168902
Summary
This study is testing a new eye drop called BL1107 to see if it is safe and effective for controlling eye pressure in adults with glaucoma or ocular hypertension. Researchers will compare two strengths of BL1107 against a standard eye drop (timolol) over 28 days. The main goal is to see if the new drops help preserve vision by measuring changes in the visual field.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Andover Eye Associates
NOT_YET_RECRUITINGAndover, Massachusetts, 01810, United States
-
Central Florida Eye Associates
NOT_YET_RECRUITINGLakeland, Florida, 33805, United States
-
Eye Research Foundation
RECRUITINGNewport Beach, California, 92663, United States
-
Global Research Management, Inc.
RECRUITINGGlendale, California, 91204, United States
-
Lee Shettle Eye and Hearing
RECRUITINGLargo, Florida, 33773, United States
-
Levenson Eye Associates
NOT_YET_RECRUITINGJacksonville, Florida, 32204, United States
-
Scott & Christie and Associates, PC
NOT_YET_RECRUITINGCranberry Township, Pennsylvania, 16066, United States
-
Total Eye Care, P.A.
RECRUITINGMemphis, Tennessee, 38119, United States
Conditions
Explore the condition pages connected to this study.